Evotec to acquire Aptuit

15:28 EDT 1 Aug 2017 | CentreWatch

Evotec and Aptuit announced that they have entered into a definitive agreement under which Evotec will acquire Aptuit for $300 million. This transaction will strengthen Evotec’s position as the leading global player in the external innovation marketplace. As a partner research organization for integrated outsourced drug discovery and development solutions, Aptuit offers highly synergistic scientific […]

The post Evotec to acquire Aptuit appeared first on CenterWatch News Online.

Original Article: Evotec to acquire Aptuit


More From BioPortfolio on "Evotec to acquire Aptuit"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...